Clinical trial Recruiting at 1 site Observational

Registry for Hereditary Spastic Paraplegia to Support Future Treatments

Official title: STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies

Run by IRCCS Fondazione Stella Maris · NCT06572046 · Data updated 2026-11-12

This study is creating a database to track people with hereditary spastic paraplegia over time to help understand the condition better and support future treatments.

Quick facts

Study typeObservational
SexAll
Enrollment500 (estimated)
SponsorIRCCS Fondazione Stella Maris
Academic / other
Locations1 site (Pisa)
StatusRecruiting
StartedJanuary 24, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2029
Registry record updatedMarch 27, 2026
Trial IDNCT06572046 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with a clinical diagnosis of pure or complex hereditary spastic paraplegia, regardless of genetic diagnosis.

Probably not a fit

Patients with secondary forms of hereditary spastic paraplegia or significant comorbidities that affect their clinical picture may not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to create a comprehensive database of patients affected by hereditary spastic paraplegia (HSP) to facilitate the collection and management of patient data over time. It will involve five clinical centers where participants will be assessed annually, allowing for the monitoring of disease progression and the development of clinical outcome measures. The registry will utilize validated clinical scales, biomarkers, and patient-reported outcomes to capture the phenotypic complexity of HSP. Biological samples will also be collected for future research and analysis.

Why it matters

Potential benefit: If successful, this registry could enhance the understanding of hereditary spastic paraplegia and pave the way for the development of targeted therapies.

How similar studies have gone: Other registries for rare diseases have shown success in facilitating research and improving patient outcomes, suggesting a positive outlook for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* clinical diagnosis of pure or complex HSP/spastic ataxia, even in the absence of a known genetic diagnosis
* participants/parents/legal guardians will have to give informed consent for enrollment in the registry and privacy data management

Exclusion Criteria:

* subjects affected by secondary forms of HSP
* presenting comorbidities that affect the general clinical picture according to clinical judgment
* lack of informed consent

Where it's running

  • IRCCS Fondazione Stella Maris
    Pisa, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.